Intrinsic relative potency of a series of pyrrolizidine alkaloids characterized by rate and extent of metabolism.


Journal

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
ISSN: 1873-6351
Titre abrégé: Food Chem Toxicol
Pays: England
ID NLM: 8207483

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 12 03 2019
revised: 17 05 2019
accepted: 18 05 2019
pubmed: 28 5 2019
medline: 20 8 2019
entrez: 27 5 2019
Statut: ppublish

Résumé

1,2-Unsaturated pyrrolizidine alkaloids (PAs) are sometimes present in foods or herbal supplements/medicines as impurities and pose potential concerns for liver genotoxicity/carcinogenicity. PAs display a strong structure toxicity relationship, however, current regulatory approaches to risk assessment take the precautionary approach of assuming all PAs display the same potency as the most toxic congeners lasiocarpine (LAS) and riddelliine (RID). Here we explore the relative potencies of a series of structurally diverse PAs by measuring DNA adduct formation in vitro in a rat sandwich culture hepatocyte (SCH) cell system. The adducts generated are consistent with those identified in vivo as biomarkers of PA exposure and potential liver-tumor formation. DNA reactive PAs require metabolic activation to form intermediates that bind DNA, therefore, adduct formation is a direct reflection of reactive metabolite formation. Since the area under the concentration versus time curve (AUC) for the depletion of parent PA from the extracellular media is a measure of PA exposure, the ratio of adducts/AUC provides a measure of hepatocyte exposure to DNA-binding metabolites corresponding to an intrinsic potency for DNA adduct formation. Intrinsic potencies relative to potencies for LAS compare well with existing relative potency data further affirming that PA toxicity varies considerably with chemical structure.

Identifiants

pubmed: 31129256
pii: S0278-6915(19)30298-4
doi: 10.1016/j.fct.2019.05.031
pii:
doi:

Substances chimiques

DNA Adducts 0
Pyrrolizidine Alkaloids 0
dehydrosupinidine 27628-47-3

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110523

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Cathy Lester (C)

Procter & Gamble, Mason Business Center, 8700 Mason - Montgomery Rd, Mason, OH, 45040, USA. Electronic address: lester.cc@pg.com.

John Troutman (J)

Procter & Gamble, Mason Business Center, 8700 Mason - Montgomery Rd, Mason, OH, 45040, USA.

Cindy Obringer (C)

Procter & Gamble, Mason Business Center, 8700 Mason - Montgomery Rd, Mason, OH, 45040, USA.

Kenneth Wehmeyer (K)

Procter & Gamble, Mason Business Center, 8700 Mason - Montgomery Rd, Mason, OH, 45040, USA.

Peter Stoffolano (P)

Procter & Gamble, Mason Business Center, 8700 Mason - Montgomery Rd, Mason, OH, 45040, USA.

Michael Karb (M)

Procter & Gamble, Mason Business Center, 8700 Mason - Montgomery Rd, Mason, OH, 45040, USA.

Yan Xu (Y)

Procter & Gamble, Mason Business Center, 8700 Mason - Montgomery Rd, Mason, OH, 45040, USA.

Amy Roe (A)

Procter & Gamble, Mason Business Center, 8700 Mason - Montgomery Rd, Mason, OH, 45040, USA.

Greg Carr (G)

Procter & Gamble, Mason Business Center, 8700 Mason - Montgomery Rd, Mason, OH, 45040, USA.

Karen Blackburn (K)

Procter & Gamble, Mason Business Center, 8700 Mason - Montgomery Rd, Mason, OH, 45040, USA.

Catherine Mahony (C)

Procter & Gamble Technical Centre, Whitehall Lane, Egham, Surrey, TW20 9AW, UK.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH